Loading
A methylation blood test for six common cancers announced by AnchorDx of Guangzhou in 2020 at a target cost of about $100; whether it reached the market could not be confirmed.
AnchorDx, a Guangzhou diagnostics company, announced Aurora in a press release of 25 June 2020 as a methylated circulating tumour DNA test for lung, breast, colorectal, gastric, oesophageal and liver cancer, which it said make up 65% of new cancer cases in China, at a cost as low as $100; the release gave no accuracy figures. The closest peer-reviewed work found is an AnchorDx-authored two-cancer study (Lei et al., American Journal of Cancer Research 2024: 407 plasma samples, colorectal and gastric cancer), which reported 81.3% sensitivity at 80% specificity in its validation set, a specificity far too low for screening. No launch, regulatory status or price after 2020 was found.
Reads methylated circulating tumour DNA in blood, as the company described it in 2020; AnchorDx has published single-cancer methylation assays for lung, bladder, kidney and colorectal cancer.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Aurora" OR ABSTRACT:"Aurora" OR TITLE:"AnchorDx" OR ABSTRACT:"AnchorDx") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Aurora (AnchorDx), not a curated reading list.
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/